Gordon E. Neal

Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin.

John D. Hayes, D J Judah, Gordon E. Neal · PubMed · 1993 · 110 citations

Pharmacy, Biochemistry, Toxicology +16

Metabolic basis of the species difference to aflatoxin B1 induced hepatotoxicity

Kym A.F. O'Brien, Elizabeth J. Moss, D J Judah et al. · Biochemical and Biophysical Research Communications · 1983 · 108 citations

Pharmacy, Biochemistry, Toxicology +16

Increased bioactivation of dihaloalkanes in rat liver due to induction of class Theta glutathione S-transferase T1-1

Philip J. Sherratt, Margaret M. Manson, Anne M. Thomson et al. · Biochemical Journal · 1998 · 86 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo–keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase

Linda S. Ireland, David J. Harrison, Gordon E. Neal et al. · Biochemical Journal · 1998 · 84 citations · Full text

Medicine, Biochemistry, Pharmacology +14

The metabolism of aflatoxin B1 by human liver

Elizabeth J. Moss, Gordon E. Neal · Biochemical Pharmacology · 1985 · 40 citations

Pharmacy, Biochemistry, Toxicology +12